250 related articles for article (PubMed ID: 31902694)
61. A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
Wagle M; Eiring AM; Wongchenko M; Lu S; Guan Y; Wang Y; Lackner M; Amler L; Hampton G; Deininger MW; O'Hare T; Yan Y
Leukemia; 2016 Jul; 30(7):1493-501. PubMed ID: 27044711
[TBL] [Abstract][Full Text] [Related]
62. [Detection of BCR-ABL1 chimeric gene-positive neutrophils in a patient with mixed phenotype acute leukemia].
Nagasawa F; Nakamura Y; Tokita K; Takahashi W; Iso H; Arai H; Tsurumi S; Handa T; Nakamura Y; Nakamura Y; Sasaki K; Mitani K
Rinsho Ketsueki; 2013 Nov; 54(11):2074-8. PubMed ID: 24305542
[TBL] [Abstract][Full Text] [Related]
63. BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients.
McCarron SL; O'Connor LM; Langabeer SE; Conneally E
Genet Test Mol Biomarkers; 2013 Feb; 17(2):170-3. PubMed ID: 23289634
[TBL] [Abstract][Full Text] [Related]
64. Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.
Soverini S; De Benedittis C; Polakova KM; Linhartova J; Castagnetti F; Gugliotta G; Papayannidis C; Mancini M; Klamova H; Salvucci M; Crugnola M; Iurlo A; Albano F; Russo D; Rosti G; Cavo M; Baccarani M; Martinelli G
Oncotarget; 2016 Apr; 7(16):21982-90. PubMed ID: 26980736
[TBL] [Abstract][Full Text] [Related]
65. NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.
Catalano G; Niscola P; Banella C; Diverio D; Trawinska MM; Fratoni S; Iazzoni R; De Fabritiis P; Abruzzese E; Noguera NI
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020083. PubMed ID: 33194157
[TBL] [Abstract][Full Text] [Related]
66. Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.
Cavelier L; Ameur A; Häggqvist S; Höijer I; Cahill N; Olsson-Strömberg U; Hermanson M
BMC Cancer; 2015 Feb; 15():45. PubMed ID: 25880391
[TBL] [Abstract][Full Text] [Related]
67. p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).
Cividin M; Brizard F; Sorel N; Renaud M; Guilhot F; Brizard A
Leuk Res; 2004 Jan; 28(1):97-9. PubMed ID: 14630086
[TBL] [Abstract][Full Text] [Related]
68. Chronic myeloid leukemia in patient with the Klinefelter syndrome.
Andreieva SV; Korets KV; Kyselova OA; Ruzhinska OE; Serbin IM
Exp Oncol; 2016 Sep; 38(3):195-7. PubMed ID: 27685529
[TBL] [Abstract][Full Text] [Related]
69. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
70. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
[TBL] [Abstract][Full Text] [Related]
71. Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia.
Zhang Z; Chen Z; Jiang M; Liu S; Guo Y; Wan L; Li F
BMC Cancer; 2019 Oct; 19(1):935. PubMed ID: 31594548
[TBL] [Abstract][Full Text] [Related]
72. Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts.
Xue M; Wang Q; Huo L; Wen L; Yang X; Wu Q; Pan J; Cen J; Ruan C; Wu D; Chen S
Leuk Lymphoma; 2019 Dec; 60(12):3051-3057. PubMed ID: 31258010
[TBL] [Abstract][Full Text] [Related]
73. Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses.
Nawata R; Shinohara K; Yamada T; Takahashi T; Katsuki K; Takeda K; Kameda N; Ariyoshi K; Ota I; Muraki K
Int J Hematol; 2000 Jun; 71(4):353-8. PubMed ID: 10905055
[TBL] [Abstract][Full Text] [Related]
74. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
[TBL] [Abstract][Full Text] [Related]
75. Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities.
Han E; Lee H; Kim M; Kim Y; Han K; Lee SE; Kim HJ; Kim DW
Blood Res; 2014 Mar; 49(1):22-8. PubMed ID: 24724063
[TBL] [Abstract][Full Text] [Related]
76. Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group.
Itonaga H; Tsushima H; Imanishi D; Hata T; Doi Y; Mori S; Sasaki D; Hasegawa H; Matsuo E; Nakashima J; Kato T; Horai M; Taguchi M; Matsuo M; Taniguchi H; Makiyama J; Sato S; Horio K; Ando K; Moriwaki Y; Sawayama Y; Ogawa D; Yamasaki R; Takasaki Y; Imaizumi Y; Taguchi J; Kawaguchi Y; Yoshida S; Joh T; Moriuchi Y; Nonaka H; Soda H; Fukushima T; Nagai K; Kamihira S; Tomonaga M; Yanagihara K; Miyazaki Y
Leuk Res; 2014 Jan; 38(1):76-83. PubMed ID: 24262285
[TBL] [Abstract][Full Text] [Related]
77. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with
Mizuno S; Takami A; Kawamura K; Harada K; Masayoshi M; Yano S; Ito A; Ozawa Y; Ouchi F; Ashida T; Nawa Y; Ichinohe T; Fukuda T; Atsuta Y; Yanada M
EJHaem; 2024 Apr; 5(2):369-378. PubMed ID: 38633128
[No Abstract] [Full Text] [Related]
78. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction.
Han JY; Theil KS
Cancer Genet Cytogenet; 2006 Feb; 165(1):70-4. PubMed ID: 16490599
[TBL] [Abstract][Full Text] [Related]
79. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract][Full Text] [Related]
80. Reactive oxygen species in BCR-ABL1-expressing cells - relevance to chronic myeloid leukemia.
Antoszewska-Smith J; Pawlowska E; Blasiak J
Acta Biochim Pol; 2017; 64(1):1-10. PubMed ID: 27904889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
